Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00294060 · ClinicalTrials.gov registry record
P3: Pacemaker Patient Profiling Study
A clinical trial, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Terminated
- Registry status
- 2,013
- Enrollment target
NCT00294060: Clinical Trial study, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
NCT00294060 is a clinical trial that was terminated before completion, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 2,013 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00294060 was terminated before completion, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- TERMINATED
- Registry status
- 2,013 participants
- Enrollment target
Study Summary
The P3 Study is a United States post market study to gather data on clinical status, primary indications, device therapy choices, clinical management and outcomes for patients with implantable pacemakers.
Primary Outcome
Pacemaker device choice characterized by the number of patients with dual chamber devices
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,013 participants |
| Start Date | 2004-03 |
| Est. Completion | 2007-11 |
Why NCT00294060 stopped before completion
NCT00294060 is an observational study that tracks outcomes without assigning an intervention. Its 2,013 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00294060 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00294060 about?
NCT00294060 is a clinical study titled "P3: Pacemaker Patient Profiling Study". The P3 Study is a United States post market study to gather data on clinical status, primary indications, device therapy choices, clinical management and outcomes for patients with implantable pacemakers.
What is the current status of trial NCT00294060?
This trial is currently terminated. The enrollment target is 2,013 participants. The study started on 2004-03. Estimated completion is 2007-11.
Who is sponsoring clinical trial NCT00294060?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04604509 · 2,010 participants · Phase 4
Nicotine Replacement Therapy, Counseling, Varenicline, and Bupropion for Smoking Cessation, the PISCES I Trial
- NCT04100564 · 2,009 participants · NA
LITES Task Order 0005 Prehospital Airway Control Trial (PACT)
- NCT05059444 · 2,020 participants
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia